PT3810587T - Alcoxipiridinilindolsulfonamidas substituídas - Google Patents

Alcoxipiridinilindolsulfonamidas substituídas

Info

Publication number
PT3810587T
PT3810587T PT197312838T PT19731283T PT3810587T PT 3810587 T PT3810587 T PT 3810587T PT 197312838 T PT197312838 T PT 197312838T PT 19731283 T PT19731283 T PT 19731283T PT 3810587 T PT3810587 T PT 3810587T
Authority
PT
Portugal
Prior art keywords
indolsulfonamides
alkoxypyridinyl
substituted
substituted alkoxypyridinyl
alkoxypyridinyl indolsulfonamides
Prior art date
Application number
PT197312838T
Other languages
English (en)
Original Assignee
Ucb Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Gmbh filed Critical Ucb Pharma Gmbh
Publication of PT3810587T publication Critical patent/PT3810587T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
PT197312838T 2018-06-20 2019-06-19 Alcoxipiridinilindolsulfonamidas substituídas PT3810587T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18178773.0A EP3584244A1 (en) 2018-06-20 2018-06-20 Substituted alkoxypyridinyl indolsulfonamides

Publications (1)

Publication Number Publication Date
PT3810587T true PT3810587T (pt) 2022-11-14

Family

ID=62715911

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197312838T PT3810587T (pt) 2018-06-20 2019-06-19 Alcoxipiridinilindolsulfonamidas substituídas

Country Status (14)

Country Link
US (1) US11976056B2 (pt)
EP (3) EP3584244A1 (pt)
JP (1) JP7371031B2 (pt)
CN (1) CN112292375B (pt)
CA (1) CA3101086A1 (pt)
DK (1) DK3810587T3 (pt)
ES (1) ES2929829T3 (pt)
HR (1) HRP20221289T1 (pt)
HU (1) HUE060181T2 (pt)
LT (1) LT3810587T (pt)
MX (1) MX2020012823A (pt)
PL (1) PL3810587T3 (pt)
PT (1) PT3810587T (pt)
WO (1) WO2019243398A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020254289A1 (en) * 2019-06-17 2020-12-24 Ucb Pharma Gmbh N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as gpr17 modulators for treating cns disorders such as multiple sclerosis
CN112375027B (zh) * 2020-12-07 2023-03-31 中国药科大学 吲哚磺酰胺类衍生物及其医药用途
PE20240125A1 (es) * 2021-02-26 2024-01-22 Hoffmann La Roche Derivados novedosos de pirimidin-2-il sulfonamida
WO2023241960A1 (en) * 2022-06-15 2023-12-21 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
EP4311828A1 (en) * 2022-07-26 2024-01-31 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
WO2024017855A1 (en) * 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel isothiazol-3-yl and isoxazol-3-yl sulfonamide compounds
WO2024017858A1 (en) * 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel naphthyl and isoquinoline sulfonamide derivatives
WO2024017863A1 (en) * 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel pyrimidinyl and triazinyl sulfonamide derivatives
WO2024017857A1 (en) 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel imidazopyridine and pyrazolopyridine sulfonamide derivatives
WO2024017856A1 (en) 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel isoquinolinone, pyrrolopyridinone and thienopyridinone sulfonamide derivatives
WO2024023129A1 (en) * 2022-07-28 2024-02-01 F. Hoffmann-La Roche Ag Novel 7-substituted indole sulfonamide derivatives
WO2024023128A1 (en) * 2022-07-28 2024-02-01 F. Hoffmann-La Roche Ag Novel 7-substituted indole sulfonamide derivatives
WO2024042147A2 (en) * 2022-08-26 2024-02-29 F. Hoffmann-La Roche Ag Novel deuterated pyrimidin-2-yl sulfonamide derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
SE9904750D0 (sv) 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
US7833722B2 (en) 2004-04-27 2010-11-16 Takeda Pharmaceutical Company Limited Ligands for G protein-coupled receptor protein and use thereof
ITMI20042007A1 (it) 2004-10-21 2005-01-21 Consiglio Nazionale Ricerche "modulatori del ricettore gpr17 e loro impieghi terapeutici"
EP1962837A4 (en) 2005-12-20 2011-12-14 Teikoku Pharma Usa Inc METHODS OF PERCUTANEOUS DELIVERY OF INDOLIC SEROTONIN RECEPTOR AGONIST AND PERCUTANEOUS COMPOSITIONS FOR USE THEREIN
WO2009000262A1 (de) 2007-06-25 2008-12-31 Acino Ag Elektrophoretisches transdermales applikationssystem
EP2355826A1 (en) * 2008-11-07 2011-08-17 The Cleveland Clinic Foundation Compounds and methods of promoting oligodendrocyte precursor differentiation
WO2011113032A2 (en) 2010-03-11 2011-09-15 Swinford Jerry L Method and apparatus for washing dowhole tubulars and equipment
EP2567698B1 (en) * 2011-09-07 2014-02-12 Rheinische Friedrich-Wilhelms-Universität Bonn GPR 17 agonists and screening assay
EP2850068B1 (en) 2012-05-09 2019-05-29 Universita' degli Studi di Milano N-(phenyl)-2-[[3-(phenyl)-1H-1,2,4-triazol-5-yl]thio]-acetamide derivatives and related compounds as G protein coupled receptor 17 (GPCR17) modulators for use in the treatment of neuro-degenerative diseases
JP7044789B2 (ja) 2016-09-24 2022-03-30 ワシントン・ユニバーシティ Sarm1 nadアーゼ活性の阻害剤およびその使用
TWI754702B (zh) * 2016-12-28 2022-02-11 德商Ucb製藥有限公司 (氮雜)吲哚-和苯並呋喃-3-磺醯胺類

Also Published As

Publication number Publication date
EP3810587A1 (en) 2021-04-28
EP3584244A1 (en) 2019-12-25
CN112292375B (zh) 2023-12-05
JP7371031B2 (ja) 2023-10-30
WO2019243398A1 (en) 2019-12-26
JP2021527696A (ja) 2021-10-14
HUE060181T2 (hu) 2023-02-28
LT3810587T (lt) 2022-11-25
ES2929829T3 (es) 2022-12-01
EP3810587B1 (en) 2022-08-10
US11976056B2 (en) 2024-05-07
HRP20221289T1 (hr) 2022-12-23
US20210214337A1 (en) 2021-07-15
CN112292375A (zh) 2021-01-29
MX2020012823A (es) 2021-02-15
CA3101086A1 (en) 2019-12-26
DK3810587T3 (da) 2022-10-31
EP4086248A1 (en) 2022-11-09
PL3810587T3 (pl) 2023-02-06

Similar Documents

Publication Publication Date Title
DK3793565T3 (en) Mcl-1-inhibitorer
DK3467457T3 (en) Vibrationssensor
DK3759096T3 (en) Cd73-inhibitorer
HUE060181T2 (hu) Szubsztituált alkoxipiridinil-indolszulfonamidok
CA185383S (en) Casque
CA185382S (en) Casque
CA185384S (en) Casque
CA185385S (en) Casque
DK3773537T3 (en) Stat3-hæmmere
DK3554057T3 (en) Audioheadsetsystem
DK3768830T3 (en) Cancerterapi
DK3613739T3 (en) Integrin-antagonister
DK3753395T3 (en) Indvendigt luftstyringssystem
DK3872428T3 (en) Indvendigt luftstyringssystem
CA184989S (en) Uroflowmeter
DK3633783T3 (en) Universal-powerbank
CA184994S (en) Uroflowmeter
EP3766087C0 (de) Sensformer
EP3841303C0 (de) Mikrogebläse
DK3768906T3 (en) Træmodul
DK3650069T3 (en) Trakeostomiventil
GB201802611D0 (en) Teleporter
DK3674425T3 (en) Stålwire
GB201802378D0 (en) Roadplate
GB201801914D0 (en) Mouth-guard